Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors. (2023). Cardiology and Cardiovascular Medicine, 7(2), 141-144. https://fortunejournals.org/ojs/index.php/ccm/article/view/16403